You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Phase 1, Phosphoinositide 3-kinase inhibitor, open-label crossover study

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Kidney Disease (CKD), Type 2 Diabetes (T2DM), Coronary Artery Disease (CAD) Trial in Jacksonville (Clopidogrel,

Active, not recruiting
  • Chronic Kidney Disease (CKD)
  • +2 more
  • Jacksonville, Florida
    University of Florida Jacksonville
Aug 5, 2022

Acceptability of Health Care, Adherence, Medication Trial in Durban, Pietermaritzburg, Harare (emtricitabine/tenofovir

Recruiting
  • Acceptability of Health Care
  • Adherence, Medication
  • emtricitabine/tenofovir alafenamide
  • Emtricitabine / Tenofovir Disoproxil Oral Tablet
  • Durban, KZN, South Africa
  • +2 more
Jul 12, 2022

CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies Trial in Hefei (T cell injection targeting CD7 chimeric

Recruiting
  • CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies
  • T cell injection targeting CD7 chimeric antigen receptor
  • Hefei, Anhui, China
    PersonGen.Anke Cellular Therapeutice Co., Ltd.
Dec 24, 2021

Ulcus Cruris, Ecthyma, Ulcer, Leg Trial in Zurich (IMP2 (lidocaine-23%-tetracaine-7% gel), IMP1 (EMLA 5% cream))

Recruiting
  • Ulcus Cruris
  • +3 more
  • IMP2 (lidocaine-23%-tetracaine-7% gel)
  • IMP1 (EMLA 5% cream)
  • Zurich, Switzerland
    Department of Dermatology, University Hospital of Zurich, Switze
Jun 5, 2023

Gout Trial in Zibo (HEC93077, Placebo)

Recruiting
  • Gout
  • Zibo, Shandong, China
    Peking Universicity Care of Luzhong Hospital
Apr 8, 2022

Obstructive Sleep Apnea Trial in France (Sunrise, polysomnography)

Recruiting
  • Obstructive Sleep Apnea
  • Sunrise
  • polysomnography
  • Angers, France
  • +18 more
Nov 7, 2022

Non Small Cell Lung Cancer (NSCLC) Trial in Milan (Pembrolizumab)

Active, not recruiting
  • Non Small Cell Lung Cancer (NSCLC)
  • Milan, Italy
    National Cancer Institute
Jun 8, 2021

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Acalabrutinib, Obinutuzumab)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Jul 14, 2022

Phenylketonurias Trial in Kobenhavn, Bristol, Birmingham (CGMP protein substitute, L-amino acid protein substitute)

Active, not recruiting
  • Phenylketonurias
  • CGMP protein substitute
  • L-amino acid protein substitute
  • Kobenhavn, Denmark
  • +2 more
Sep 15, 2022

Advanced Lung Cancer Trial in Jilin (IBI939, Sintilimab)

Recruiting
  • Advanced Lung Cancer
  • IBI939
  • Sintilimab
  • Jilin, China
    Jilin Province Cancer Hospital
Feb 19, 2021

Knee Osteoarthritis, Meniscus Disorder Trial in Bologna (Ultrasonographic evaluation)

Recruiting
  • Knee Osteoarthritis
  • Meniscus Disorder
  • Ultrasonographic evaluation
  • Bologna, Italy
    Istituto Ortopedico Rizzoli
Oct 27, 2023

Neurofibromatosis 1, Noonan Syndrome, Legius Syndrome Trial run by the National Cancer Institute (NCI) (Waitlist, ACT

Recruiting
  • Neurofibromatosis 1
  • +4 more
  • Waitlist
  • ACT Intervention
  • Bethesda, Maryland
    National Cancer Institute (NCI)
Feb 2, 2023

Breast Tumors Trial in La Jolla (Cirmtuzumab + Paclitaxel)

Active, not recruiting
  • Breast Neoplasms
  • Cirmtuzumab + Paclitaxel
  • La Jolla, California
    University of California, San Diego
May 16, 2022

Neovascular Age-related Macular Degeneration Trial in United States (CLS-AX, Anti-VEGF)

Completed
  • Neovascular Age-related Macular Degeneration
  • Phoenix, Arizona
  • +10 more
Dec 1, 2022

Head Neck Cancer, Head and Neck Tumors, Squamous Cell Carcinoma of Head and Neck Trial in Chicago (Xevinapant, Carboplatin,

Not yet recruiting
  • Head and Neck Cancer
  • +2 more
  • Chicago, Illinois
    University of Chicago Medicine Comprehensive Cancer Center
Oct 25, 2023

Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma, Locally Advanced and/or Metastatic Inflammatory

Active, not recruiting
  • Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma
  • +5 more
  • Crizotinib (PF-02341066)
  • Brussels, Belgium
  • +24 more
May 9, 2022

Anaplastic Astrocytoma, Glioblastoma, Oligodendroglioma Trial (drug, device, other, radiation, procedure, biological)

Withdrawn
  • Anaplastic Astrocytoma
  • +3 more
  • Extended Release Flucytosine
  • +7 more
  • (no location specified)
Mar 20, 2020

Opioid-use Disorder Trial in New York (Buprenorphine, Naltrexone, Vivitrol)

Terminated
Has Results
  • Opioid-use Disorder
  • New York, New York
    New York State Psychiatric Institute
Feb 4, 2022

Parkinson's Disease Trial in Dallas (Gold Nanocrystals)

Completed
  • Parkinson's Disease
  • Gold Nanocrystals
  • Dallas, Texas
    UT Southwestern
Nov 18, 2021

Non Small Cell Lung Cancer Trial in Shang'ai (Camrelizumab)

Recruiting
  • Non Small Cell Lung Cancer
  • Shang'ai, Shanghai, China
    Shanghai Pulmonary Hospital
Dec 6, 2020

AML, FLT3-ITD Mutation Trial in Hong Kong (Quizartinib, Omacetaxine Mepesuccinate Injection)

Unknown status
  • AML
  • FLT3-ITD Mutation
  • Hong Kong, Hong Kong
    The University of Hong Kong
Dec 9, 2020

NSCLC NSCLC Trial in Pittsburgh, Dallas (durvalumab)

Completed
  • Non-Small Cell Lung Cancer NSCLC
  • Pittsburgh, Pennsylvania
  • +1 more
Aug 2, 2022

Chronic Cluster Headache Trial in Buderim (PRIMUS)

Recruiting
  • Chronic Cluster Headache
  • PRIMUS
  • Buderim, Queensland, Australia
    Resolve Pain
May 11, 2023

Giant Cell Arteritis Trial in Boston (Tocilizumab, Prednisone)

Recruiting
  • Giant Cell Arteritis
  • Boston, Massachusetts
    Massachusetts General Hospital
Jul 23, 2021

Advanced Solid Tumours, NSCLC, Head and Neck Squamous Cell Carcinoma Trial in Singapore (Oral Dacomitinib)

Recruiting
  • Advanced Solid Tumours
  • +2 more
  • Oral Dacomitinib
  • Singapore, Singapore
  • +1 more
May 10, 2022